Global manufacturing facilities in Biberach, Vienna, Fremont, CA, and Shanghai

Wherever you are, we are by your side.

Our network of manufacturing facilities spans the globe, from Fremont, California in the United States to Biberach in Germany, Vienna in Austria and Shanghai in China. From these sites, we offer our customers first class biopharmaceutical medicines anywhere in the world and the best suited business model and production site for their needs. 

To keep our network dynamic and agile, we continuously invest in our people and our facilities. While extensive training programmes ensure we are always at the cutting edge of knowledge and know-how, investments in our facilities include updates to our state-of-the-art technologies as well as capacity expansions in our production facilities to meet the ever increasing demand for development and manufacturing. At currently over 290 kL commercial capacity for cell culture and over 12 kL commercial capacity for microbial and yeast fermentation, we are well prepared to meet that demand.

Whatever you need, we can provide it.

Mammalian manufacturing facility: Biberach, Germany
Europe’s largest bio­pharmaceutical multiproduct facility for mammalian cell culture and Center of Excellence for cell line development.
Read more
Mammalian manufacturing facility: Fremont, CA, USA
Mammalian manufacturing plant with two identical trains for cell culture, dedicated to the manufacture of monoclonal antibody medicines.
Read more
Microbial manufacturing facility: Vienna, Austria
Microbial manufacturing plant, producing recombinant vaccines, antibody-like molecules and pDNA from microorganisms and yeast.
Read more
Mammalian manufacturing facility: Shanghai, China
First multinational mammalian manufacturing plant in Asia, offering the manufacture of monoclonal antibodies and recombinant proteins.
Read more